VWM
DSGN icon

Venturi Wealth Management’s Design Therapeutics DSGN Stock Holding History

Venturi Wealth Management’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-753
Closed -$4.65K – 905
2024
Q4 		$4.65K Buy
+753
New +$4.36K ﹤0.01% 1695

Other funds holding DSGN

SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Venturi Wealth Management's DSGN Position: Q1 2025 in Review

Venturi Wealth Management sold out of Design Therapeutics (DSGN) in Q1 2025, closing a stake of 753 shares — an estimated $4.65K sold.

Venturi Wealth Management first reported a position in DSGN in Q4 2024 and held it in 1 quarter. The position peaked at $4.65K in Q4 2024. 98 funds tracked by Wall St. Rank hold DSGN as of Q1 2025.

  • Venturi Wealth Management reported no remaining Design Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Venturi Wealth Management sold 753 Design Therapeutics shares in Q1 2025, an estimated $4.65K.
  • Venturi Wealth Management first reported a position in Design Therapeutics in Q4 2024 and held it in 1 quarter.
  • Venturi Wealth Management's Design Therapeutics position peaked at $4.65K in Q4 2024.
  • 98 funds tracked by Wall St. Rank held Design Therapeutics as of Q1 2025.

Based on Venturi Wealth Management's 13F filing for Q1 2025, filed 6 May 2025.